Answers are grounded in this paper and cite their sources.
Intervertebral disc degeneration is one of the primary contributors to chronic low back pain, yet effective therapies remain limited owing to the persistent oxidative stress and inflammatory microenvironment within the nucleus pulposus. Excessive reactive oxygen species (ROS) accumulation activates pyroptosis and amplifies inflammatory cascades, thereby accelerating disc degeneration. Herein, an injectable reactive oxygen species-responsive hydrogel (GCTD) is developed to simultaneously scavenge ROS and suppress pyroptosis for nucleus pulposus microenvironment remodeling and intervertebral disc degeneration treatment. The hydrogel is constructed by incorporating cyclodextrin-modified gelatin methacryloyl for effective delivery of disulfiram, a potent pyroptosis inhibitor, together with scavenging-ROS thioketal crosslinkers. In situ injection of GCTD into degenerated rat intervertebral discs retains disc height and maintains the structural integrity of nucleus pulposus tissue. These findings may provide a new therapy for intervertebral disc degeneration to remodel the inflammatory microenvironment of the nucleus pulposus.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: